Trial Profile
A proof-of-concept study of PRX-106 in patients with non alcoholic steatohepatitis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions; Proof of concept
- 07 Oct 2015 New trial record